Improved understanding of the effect of food on drug absorption and bioavailability for lipophilic compounds using an intestinal pig perfusion model
article
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability 1993
- A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids 2000
- Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single‐ and Double‐Peak Phenomena in the Plasma Profiles 1993
References (31)
- Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single‐ and Double‐Peak Phenomena in the Plasma Profiles via openalex
- A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids via openalex
- Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability via openalex
- doi:10.1016/s0002-9343(70)80127-9 via openalex
- doi:10.1023/a:1016062224568 via openalex
- doi:10.1002/bdd.2510040203 via openalex
- doi:10.1016/s0378-5173(01)00897-3 via openalex
- doi:10.1016/j.ejpb.2005.01.003 via openalex
- doi:10.1016/j.ijpharm.2004.08.001 via openalex
- W6693089268 via openalex
- doi:10.1124/dmd.105.008409 via openalex
- doi:10.1007/s11095-006-9607-z via openalex
- doi:10.1021/bi00406a013 via openalex
- doi:10.1002/jps.10329 via openalex
- doi:10.1023/a:1016212804288 via openalex
- doi:10.1211/0022357021771896 via openalex
- doi:10.1016/j.ejpb.2004.03.001 via openalex
- doi:10.1016/s0731-7085(02)00467-3 via openalex
- doi:10.1023/a:1023481418576 via openalex
- doi:10.1002/1520-6017(200008)89:8<1073::aid-jps12>3.0.co;2-v via openalex
- doi:10.1002/jps.2600670706 via openalex
- doi:10.1111/j.1365-2125.1993.tb05699.x via openalex
- doi:10.1007/s11095-004-9004-4 via openalex
- doi:10.1016/s0090-9556(25)07353-2 via openalex
- doi:10.1021/mp034006h via openalex
- doi:10.1023/a:1023891320858 via openalex
- doi:10.1111/j.2042-7158.1997.tb06084.x via openalex
- doi:10.1016/j.ijpharm.2004.01.014 via openalex
- doi:10.1021/js950221g via openalex
- doi:10.1002/jps.2600710120 via openalex
- doi:10.1007/s11095-005-8192-x via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:10:27.824888+00:00
License: CC0
· commercial use OK